APA (7th ed.) Citation

Ledziński, Ł., Grześk, G., Ziołkowski, M., Waligóra, M., Kurzyna, M., Mularek-Kubzdela, T., . . . Florczyk, M. (2026). Clinically Actionable Explainable AI in Pulmonary Arterial Hypertension: Endpoints, Calibration, and External Validation. Reply to Pagnoni et al. Toward Clinically Actionable Explainable AI in Pulmonary Arterial Hypertension: Endpoints, Calibration, and External Validation. Comment on "Ledziński et al. Personalized Medicine in Pulmonary Arterial Hypertension: Utilizing Artificial Intelligence for Death Prevention. J. Clin. Med. 2025, 14 , 8325". Journal of Clinical Medicine, 15(5), 1838. https://doi.org/10.3390/jcm15051838

Chicago Style (17th ed.) Citation

Ledziński, Łukasz, et al. "Clinically Actionable Explainable AI in Pulmonary Arterial Hypertension: Endpoints, Calibration, and External Validation. Reply to Pagnoni Et Al. Toward Clinically Actionable Explainable AI in Pulmonary Arterial Hypertension: Endpoints, Calibration, and External Validation. Comment on "Ledziński Et Al. Personalized Medicine in Pulmonary Arterial Hypertension: Utilizing Artificial Intelligence for Death Prevention. J. Clin. Med. 2025, 14 , 8325"." Journal of Clinical Medicine 15, no. 5 (2026): 1838. https://doi.org/10.3390/jcm15051838.

MLA (9th ed.) Citation

Ledziński, Łukasz, et al. "Clinically Actionable Explainable AI in Pulmonary Arterial Hypertension: Endpoints, Calibration, and External Validation. Reply to Pagnoni Et Al. Toward Clinically Actionable Explainable AI in Pulmonary Arterial Hypertension: Endpoints, Calibration, and External Validation. Comment on "Ledziński Et Al. Personalized Medicine in Pulmonary Arterial Hypertension: Utilizing Artificial Intelligence for Death Prevention. J. Clin. Med. 2025, 14 , 8325"." Journal of Clinical Medicine, vol. 15, no. 5, 2026, p. 1838, https://doi.org/10.3390/jcm15051838.